Colorectal cancer is shifting in worrying ways: younger adults are accounting for a much larger share of new cases, rectal tumors are increasing, and screening rates remain low in the groups now at higher risk. This piece walks through the latest findings, who is most affected, what behaviors are implicated, and why early detection makes such a dramatic difference. The data come from a major cancer statistics report and show clear trends that demand action from doctors and the public alike.
The overall picture shows falling colorectal cancer deaths in older adults even as diagnoses climb among people 65 and under. Adults 65 and younger now make up about 45% of new colorectal cancer cases, a big jump from roughly 27% in the mid-1990s. That shift means almost half of new cases are appearing in younger generations who historically had much lower risk.
The increase is striking in younger adults: incidence is rising fastest among people aged 20 to 49, at about 3% per year. Rectal cancers are becoming a larger share of the total, now roughly one-third of all colorectal cancer cases compared with closer to 27% two decades ago. These changes point to shifts in exposures, behavior, or other risk factors that differ from older cohorts.
Worryingly, when colorectal cancer strikes people 50 and under it is often advanced: about 75% of those cancers in younger adults are found at an advanced stage. Half of the cases in the under-50 bracket occur between ages 45 and 49, a window when routine screening is now recommended but still underused. Only around 37% of people in that 45 to 49 age range are getting screened as recommended, leaving many cancers undetected until they are harder to treat.
“After decades of progress, the risk of dying from colorectal cancer is climbing in younger generations of men and women, confirming a real uptick in disease because of something we’re doing or some other exposure,” Rebecca Siegel warned in the report. She is a senior scientific director for surveillance research at the American Cancer Society and led the study that produced these findings. Her point is blunt: this is not random noise, and the pattern needs targeted investigation.
“We need to redouble research efforts to understand the cause, but also circumvent deaths through earlier detection by educating clinicians and the general public about symptoms and increasing screening in people 45-54 years,” the report urges. That recommendation pairs research with practical steps: educate, screen, and catch cancers earlier when they are far easier to treat. Increasing awareness of symptoms and lowering barriers to screening are concrete moves that can reduce the rising toll.
The report projects roughly 158,850 new colorectal cancer cases this year and about 55,230 deaths from the disease. Those are sobering numbers that underline how far we still have to go, even as treatment and outcomes have improved for those diagnosed early. When cancer is caught at a local stage, the five-year survival rate is about 95%, which shows the life-saving power of early detection.
Researchers estimate more than half of colorectal cancer cases can be traced to high-risk behaviors and exposures. Key contributors include poor diet and nutrition, heavy alcohol use, tobacco use, physical inactivity, and obesity. That mix of lifestyle factors suggests both prevention and policy interventions can make a difference if they are prioritized.
“These findings further underscore that colorectal cancer is worsening among younger generations and highlight the immediate need for eligible adults to begin screening at the recommended age of 45,” said Dr. William Dahut, a chief scientific officer at the American Cancer Society. He adds that the trends also point to gaps in research and care that must be fixed quickly. “The report also shines a light on the crucial importance of continued funding for research to help discover new therapies to treat the disease and advance patient care.”
